Abstract
Justin Stebbing1,2† & Pramod Srivastava3 †Author for correspondence 1The Hammersmith Hospitals NHS Trust, Charing Cross Hospital, Department of Medical Oncology, 1st Floor, E Wing, Fulham Palace Road, London W6 8RF, UK Tel.: +44 208 746 8295; +44 777 958 7565; Fax: +44 208 846 1433; E-mail: j.stebbing@ic.ac.uk 2Imperial College London, Hammersmith Hospital Campus, 8th Floor, Cyclotron Building, Du Cane Road, London W12 0NN, UK 3University of Connecticut School of Medicine, Center for Immunotherapy of Cancer and Infectious Diseases, Farmington, Connecticut 06030–1601, USA “The discovery of the genes for heat shock proteins has now led to a clinically useful therapy.”
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.